Price movement over the last 24 hours
AFLAC Incorporated vs Herbalife Nutrition Ltd — how do they compare? AFLAC Incorporated trades at $121.41 (market cap $61.84B), while Herbalife Nutrition Ltd trades at $12.82 (market cap $1.36B). The key difference: AFLAC Incorporated is far larger — about 45.5× Herbalife Nutrition Ltd's market cap, and AFLAC Incorporated pays a 2.01% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| AFL | HLF | |
|---|---|---|
Market Cap | $61.84B | $1.36B |
Sector | Financials | Consumer Staples |
52-Week High | $121.49 | $19.96 |
52-Week Low | $98.09 | $7.75 |
Enterprise Value | $70.50B | $3.09B |
Dividend Yield | 2.01% | — |
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
Herbalife (HLF) trades at $13.14, showing modest daily gains of 0.23%. The stock presents a mixed technical picture with neutral signals from oscillators and bearish moving averages. Fundamentally, HLF maintains strong gross margins of 77.78% and attractive valuation metrics including a P/E of 5.64 and P/S of 0.26. Recent Q1 2026 earnings beat expectations with $0.64 EPS versus $0.607 expected, while the company completed a significant $1.45 billion debt refinancing in April 2026 to strengthen its balance sheet.
HLF offers value investment appeal with deep discount valuations and improving debt trends, though negative shareholder equity and competitive pressures in the nutrition space present ongoing challenges. Analyst sentiment leans bullish with 57.7% buy ratings, but the stock faces headwinds from its multi-level marketing model scrutiny and regional market volatility. The upcoming Q2 2026 earnings on August 5 will be crucial for validating recent guidance increases.
Trailing returns across standard periods
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →